NASH WITH FIBROSIS
Clinical trials for NASH WITH FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new NASH WITH FIBROSIS trials appear
Sign up with your email to follow new studies for NASH WITH FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a simple stomach tuck reverse fatty liver disease?
Disease control Recruiting nowThis study tests whether a minimally invasive procedure called endoscopic sleeve gastroplasty (ESG), which reduces stomach size by about 70%, can help people with obesity and a serious liver condition called MASH. Participants will be randomly assigned to receive either ESG plus …
Matched conditions: NASH WITH FIBROSIS
Phase: NA • Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New drug could stop liver scarring in its tracks
Disease control Recruiting nowThis study tests an experimental drug called efruxifermin in 1650 adults with a type of liver disease (NASH/MASH) and moderate liver scarring. The goal is to see if the drug can reverse the scarring and prevent serious liver problems like liver failure or need for a transplant. P…
Matched conditions: NASH WITH FIBROSIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated May 26, 2026 12:07 UTC